Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Chi

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
The Prostate|February 18, 1998
Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockadeP C Mack, S G Chi, F J Meyers, et al.
European Urology|January 1, 1997
Human androgen receptor expression in prostate cancer following androgen ablationR de Vere White, F Meyers, S G Chi, et al.
Human Pathology|June 1, 1996
Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissuesI E Wertz, A D Deitch, P H Gumerlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinomaM J Kang, B J Park, D S Byun, et al.
Journal of the National Cancer Institute|January 1, 1997
p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate NetworkP H Gumerlock, S G Chi, X B Shi, et al.
Experimental & Molecular Medicine|January 5, 1999
Heterogeneous HBV mutants coexist in Korean hepatitis B patientsW K Keum, J Y Kim, J Y Kim, et al.
Genes, Chromosomes & Cancer|February 1, 1996
Alterations of the retinoblastoma gene in human prostate adenocarcinomaJ V Tricoli, P H Gumerlock, J L Yao, et al.
Cancer Research|July 26, 2000
Frequent alteration of p63 expression in human primary bladder carcinomasB J Park, S J Lee, J I Kim, et al.
Cancer Research|September 18, 2001
Frequent epigenetic inactivation of RASSF1A in human bladder carcinomaM G Lee, H Y Kim, D S Byun, et al.
The Prostate|February 11, 1999
Overexpression of cyclin D1 is rare in human prostate carcinomaL M Gumbiner, P H Gumerlock, P C Mack, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The Prostate|February 18, 1998
Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockadeP C Mack, S G Chi, F J Meyers, et al.
European Urology|January 1, 1997
Human androgen receptor expression in prostate cancer following androgen ablationR de Vere White, F Meyers, S G Chi, et al.
Human Pathology|June 1, 1996
Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissuesI E Wertz, A D Deitch, P H Gumerlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinomaM J Kang, B J Park, D S Byun, et al.
Journal of the National Cancer Institute|January 1, 1997
p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate NetworkP H Gumerlock, S G Chi, X B Shi, et al.
Experimental & Molecular Medicine|January 5, 1999
Heterogeneous HBV mutants coexist in Korean hepatitis B patientsW K Keum, J Y Kim, J Y Kim, et al.
Genes, Chromosomes & Cancer|February 1, 1996
Alterations of the retinoblastoma gene in human prostate adenocarcinomaJ V Tricoli, P H Gumerlock, J L Yao, et al.
Cancer Research|July 26, 2000
Frequent alteration of p63 expression in human primary bladder carcinomasB J Park, S J Lee, J I Kim, et al.
Cancer Research|September 18, 2001
Frequent epigenetic inactivation of RASSF1A in human bladder carcinomaM G Lee, H Y Kim, D S Byun, et al.
The Prostate|February 11, 1999
Overexpression of cyclin D1 is rare in human prostate carcinomaL M Gumbiner, P H Gumerlock, P C Mack, et al.
Pageof 4